Abstract: An animal house has ammonia control apparatus. The animal house is a building structured for housing one or more animals. Apparatus is positioned inside the animal house for removing ammonia from air, and then returning the air inside the animal house. A method for removing ammonia from air in an animal house includes removing ammonia from air with an apparatus positioned inside the animal house, and then returning the air with ammonia removed inside the animal house.

Abstract: The invention features a press for making a football shaped pressed food that may include, e.g., a logo, insitodgnia, and/or indicium of a football, e.g., the laces, pebble-grain texture, and/or vertical stripes) imprinted therein or thereon, and methods and uses thereof.

Abstract: The present invention relates to a method of treating infections in humans by administering a single dose of azithromycin.

Abstract: The invention teaches compositions useful for treating conditions characterized by excess exfoliation or hyperkeratinization, such as dandruff. These compositions include vitamin B12 in an amount sufficient to alleviate exfoliation. Dandruff is one condition which may be treated using the formulations.

Abstract: Vitamin B12 is used to stimulate heme oxygenase production. In turn, levels of the molecules 12(R)-HETE and 12(R)-DIHETE, which are arachidonic acid derivatives, are reduced. Various topical formulations containing vitamin B12, but no other vitamins, are described.

Abstract: Vitamin B12 is used to stimulate heme oxygenase production. In turn, levels of the molecules 12(R)-HETE and 12(R)-DIHETE, which are arachidonic acid derivatives, are reduced. Various topical formulations containing vitamin B12, but no other vitamins, are described.

Abstract: The invention relates to a method for treating or preventing ocular swelling and corneal-conjunctival inflammation. This is accomplished by administering to the eye of a subject, either before or after exposure to an ocular swelling stimulus, an amount of a heme oxygenase inducing agent sufficient to increase levels of heme oxygenase in the eye and thereby to reduce or to regulate the amount of 12(R) hydroxyeicosatetraenoic and 12(R) DiHETE acids present. Particularly preferred agents include stannous compounds, such as SnCl.sub.2, other metals, heme derivatives and Vitamin B12. These compounds may be administered in various forms.

Abstract: The present invention relates to a method of and composition for reducing intraocular pressure. The method comprises administering to a patient requiring such reduction of intraocular pressure a therapeutically effective amount of 12(R)-hydroxy-eicosa-5,8,10,14-tetraenoic acid (12(R)-HETE). The method of the present invention is particularly useful in treatment of all types of glaucoma. The method is also useful in lowering intraocular pressure in preparation for eye surgery, particularly for the removal of cataracts.

Abstract: An improved, viscous, transparent, pyrogen-free, isotonic, succinylated atelocollagen solution provides an effective medium for use in viscosurgery and as a replacement for vitreous.

Abstract: Soft contact lenses are made from purified fiber collagen and mixtures of such fiber with purified solubilized collagen.

Abstract: Soft contact lenses are made from solubilized, defatted, transparent, cross-linked collagen, and/or chemically-modified collagen.

Abstract: Chemically-modified collagen membrane prepared at physiologic pH and soluble thereat provides a carrier for ophthalmic medication leaving no removable material after drug release.